APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ropivacaine Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ropivacaine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchRopivacaine Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Ropivacaine Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ropivacaine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ropivacaine Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ropivacaine Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ropivacaine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ropivacaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ropivacaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ropivacaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ropivacaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ropivacaine Injection include Zhejiang Xianju Pharmaceutical Co.,Ltd, Yangzi River Pharmaceutical Group, Jiangsu Nhwa Pharmaceutical Co.,Ltd., Jiangsu Nhwa Pharmaceutical Co.,Ltd, Pfizer, Jiangsu Hengrui Pharmaceuticals Co., Ltd., AstraZeneca, Sintetica SA and SGPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ropivacaine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ropivacaine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ropivacaine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ropivacaine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Ropivacaine Injection Segment by Company

Zhejiang Xianju Pharmaceutical Co.,Ltd

Yangzi River Pharmaceutical Group

Jiangsu Nhwa Pharmaceutical Co.,Ltd.

Jiangsu Nhwa Pharmaceutical Co.,Ltd

Pfizer

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

AstraZeneca

Sintetica SA

SGPharma

Nephron Pharmaceuticals

Manus Aktteva Biopharma LLP

Anant Pharmaceuticals

Akorn

Ropivacaine Injection Segment by Type

10 mg/mL (1%)

2 mg/mL (0.2%)

5 mg/mL (0.5%)

7.5 mg/mL (0.75%)

Ropivacaine Injection Segment by Application

Major Nerve Block

Surgical Anesthesia

Acute Pain Management

Other

Ropivacaine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ropivacaine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ropivacaine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ropivacaine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ropivacaine Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ropivacaine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ropivacaine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ropivacaine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ropivacaine Injection Industry Trends Table 2. Ropivacaine Injection Industry Drivers Table 3. Ropivacaine Injection Industry Opportunities and Challenges Table 4. Ropivacaine Injection Industry Restraints Table 5. Global Ropivacaine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ropivacaine Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ropivacaine Injection Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Ropivacaine Injection Sales Market Share by Manufacturers Table 9. Global Ropivacaine Injection Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Ropivacaine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ropivacaine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ropivacaine Injection Manufacturers, Product Type & Application Table 13. Global Ropivacaine Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ropivacaine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10 mg/mL (1%) Table 17. Major Manufacturers of 2 mg/mL (0.2%) Table 18. Major Manufacturers of 5 mg/mL (0.5%) Table 19. Major Manufacturers of 7.5 mg/mL (0.75%) Table 20. Global Ropivacaine Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Ropivacaine Injection Sales by Type (2021-2026) & (k units) Table 22. Global Ropivacaine Injection Sales by Type (2027-2032) & (k units) Table 23. Global Ropivacaine Injection Sales Market Share by Type (2021-2026) Table 24. Global Ropivacaine Injection Sales Market Share by Type (2027-2032) Table 25. Global Ropivacaine Injection Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Ropivacaine Injection Revenue by Type (2021-2026) & (k units) Table 27. Global Ropivacaine Injection Revenue by Type (2027-2032) & (k units) Table 28. Global Ropivacaine Injection Revenue Market Share by Type (2021-2026) Table 29. Global Ropivacaine Injection Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Major Nerve Block Table 31. Major Manufacturers of Surgical Anesthesia Table 32. Major Manufacturers of Acute Pain Management Table 33. Major Manufacturers of Other Table 34. Global Ropivacaine Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Ropivacaine Injection Sales by Application (2021-2026) & (k units) Table 36. Global Ropivacaine Injection Sales by Application (2027-2032) & (k units) Table 37. Global Ropivacaine Injection Sales Market Share by Application (2021-2026) Table 38. Global Ropivacaine Injection Sales Market Share by Application (2027-2032) Table 39. Global Ropivacaine Injection Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Ropivacaine Injection Revenue by Application (2021-2026) & (k units) Table 41. Global Ropivacaine Injection Revenue by Application (2027-2032) & (k units) Table 42. Global Ropivacaine Injection Revenue Market Share by Application (2021-2026) Table 43. Global Ropivacaine Injection Revenue Market Share by Application (2027-2032) Table 44. Global Ropivacaine Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Ropivacaine Injection Sales by Region (2021-2026) & (k units) Table 46. Global Ropivacaine Injection Sales Market Share by Region (2021-2026) Table 47. Global Ropivacaine Injection Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Ropivacaine Injection Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Ropivacaine Injection Sales by Country (2021-2026) & (k units) Table 51. North America Ropivacaine Injection Sales by Country (2027-2032) & (k units) Table 52. Europe Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Ropivacaine Injection Sales by Country (2021-2026) & (k units) Table 54. Europe Ropivacaine Injection Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Ropivacaine Injection Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Ropivacaine Injection Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Ropivacaine Injection Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Ropivacaine Injection Sales by Country (2027-2032) & (k units) Table 61. Global Ropivacaine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Ropivacaine Injection Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Ropivacaine Injection Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Ropivacaine Injection Revenue Market Share by Region (2021-2026) Table 65. Global Ropivacaine Injection Revenue Market Share by Region (2027-2032) Table 66. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information Table 67. Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview Table 68. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio Table 70. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development Table 71. Yangzi River Pharmaceutical Group Company Information Table 72. Yangzi River Pharmaceutical Group Business Overview Table 73. Yangzi River Pharmaceutical Group Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Yangzi River Pharmaceutical Group Ropivacaine Injection Product Portfolio Table 75. Yangzi River Pharmaceutical Group Recent Development Table 76. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information Table 77. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Business Overview Table 78. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product Portfolio Table 80. Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Development Table 81. Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Information Table 82. Jiangsu Nhwa Pharmaceutical Co.,Ltd Business Overview Table 83. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio Table 85. Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Pfizer Ropivacaine Injection Product Portfolio Table 90. Pfizer Recent Development Table 91. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information Table 92. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview Table 93. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product Portfolio Table 95. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. AstraZeneca Ropivacaine Injection Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Sintetica SA Company Information Table 102. Sintetica SA Business Overview Table 103. Sintetica SA Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Sintetica SA Ropivacaine Injection Product Portfolio Table 105. Sintetica SA Recent Development Table 106. SGPharma Company Information Table 107. SGPharma Business Overview Table 108. SGPharma Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. SGPharma Ropivacaine Injection Product Portfolio Table 110. SGPharma Recent Development Table 111. Nephron Pharmaceuticals Company Information Table 112. Nephron Pharmaceuticals Business Overview Table 113. Nephron Pharmaceuticals Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Nephron Pharmaceuticals Ropivacaine Injection Product Portfolio Table 115. Nephron Pharmaceuticals Recent Development Table 116. Manus Aktteva Biopharma LLP Company Information Table 117. Manus Aktteva Biopharma LLP Business Overview Table 118. Manus Aktteva Biopharma LLP Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Manus Aktteva Biopharma LLP Ropivacaine Injection Product Portfolio Table 120. Manus Aktteva Biopharma LLP Recent Development Table 121. Anant Pharmaceuticals Company Information Table 122. Anant Pharmaceuticals Business Overview Table 123. Anant Pharmaceuticals Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Anant Pharmaceuticals Ropivacaine Injection Product Portfolio Table 125. Anant Pharmaceuticals Recent Development Table 126. Akorn Company Information Table 127. Akorn Business Overview Table 128. Akorn Ropivacaine Injection Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Akorn Ropivacaine Injection Product Portfolio Table 130. Akorn Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Ropivacaine Injection Distributors List Table 134. Ropivacaine Injection Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Ropivacaine Injection Product Image Figure 2. Global Ropivacaine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ropivacaine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ropivacaine Injection Sales (2021-2032) & (k units) Figure 5. Global Ropivacaine Injection Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ropivacaine Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10 mg/mL (1%) Image Figure 9. 2 mg/mL (0.2%) Image Figure 10. 5 mg/mL (0.5%) Image Figure 11. 7.5 mg/mL (0.75%) Image Figure 12. Global Ropivacaine Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Ropivacaine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Ropivacaine Injection Sales Market Share by Type (2021-2032) Figure 15. Global Ropivacaine Injection Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Ropivacaine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Ropivacaine Injection Revenue Market Share by Type (2021-2032) Figure 18. Major Nerve Block Image Figure 19. Surgical Anesthesia Image Figure 20. Acute Pain Management Image Figure 21. Other Image Figure 22. Global Ropivacaine Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Ropivacaine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ropivacaine Injection Sales Market Share by Application (2021-2032) Figure 25. Global Ropivacaine Injection Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Ropivacaine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Ropivacaine Injection Revenue Market Share by Application (2021-2032) Figure 28. North America Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Ropivacaine Injection Sales Market Share by Country (2021-2032) Figure 30. U.S. Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Ropivacaine Injection Sales Market Share by Country (2021-2032) Figure 35. Germany Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Ropivacaine Injection Sales Market Share by Country (2021-2032) Figure 42. China Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Ropivacaine Injection Sales Market Share by Country (2021-2032) Figure 50. Brazil Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Ropivacaine Injection Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Ropivacaine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Ropivacaine Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Ropivacaine Injection Revenue (2021-2032) & (US$ Million) Figure 61. North America Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Ropivacaine Injection Revenue (2021-2032) & (US$ Million) Figure 63. Europe Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Ropivacaine Injection Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Ropivacaine Injection Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Ropivacaine Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Ropivacaine Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 10 mg/mL (1%)
  • 2 mg/mL (0.2%)
  • 5 mg/mL (0.5%)
  • 7.5 mg/mL (0.75%)
Applications
  • Major Nerve Block
  • Surgical Anesthesia
  • Acute Pain Management
  • Other
Companies covered
  • Zhejiang Xianju Pharmaceutical Co.,Ltd
  • Yangzi River Pharmaceutical Group
  • Jiangsu Nhwa Pharmaceutical Co.,Ltd.
  • Jiangsu Nhwa Pharmaceutical Co.,Ltd
  • Pfizer
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • AstraZeneca
  • Sintetica SA
  • SGPharma
  • Nephron Pharmaceuticals
  • Manus Aktteva Biopharma LLP
  • Anant Pharmaceuticals
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ropivacaine Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ropivacaine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ropivacaine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ropivacaine Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ropivacaine Injection Market Dynamics
  1. 2.1 Ropivacaine Injection Industry Trends
  2. 2.2 Ropivacaine Injection Industry Drivers
  3. 2.3 Ropivacaine Injection Industry Opportunities and Challenges
  4. 2.4 Ropivacaine Injection Industry Restraints
3 Ropivacaine Injection Market by Manufacturers
  1. 3.1 Global Ropivacaine Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ropivacaine Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ropivacaine Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ropivacaine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ropivacaine Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ropivacaine Injection Manufacturers, Product Type & Application
  7. 3.7 Global Ropivacaine Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ropivacaine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ropivacaine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ropivacaine Injection Tier 1, Tier 2, and Tier 3
4 Ropivacaine Injection Market by Type
  1. 4.1 Ropivacaine Injection Type Introduction
  2. 4.1.1 10 mg/mL (1%)
  3. 4.1.2 2 mg/mL (0.2%)
  4. 4.1.3 5 mg/mL (0.5%)
  5. 4.1.4 7.5 mg/mL (0.75%)
  6. 4.2 Global Ropivacaine Injection Sales by Type
  7. 4.2.1 Global Ropivacaine Injection Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ropivacaine Injection Sales by Type (2021-2032)
  9. 4.2.3 Global Ropivacaine Injection Sales Market Share by Type (2021-2032)
  10. 4.3 Global Ropivacaine Injection Revenue by Type
  11. 4.3.1 Global Ropivacaine Injection Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Ropivacaine Injection Revenue by Type (2021-2032)
  13. 4.3.3 Global Ropivacaine Injection Revenue Market Share by Type (2021-2032)
5 Ropivacaine Injection Market by Application
  1. 5.1 Ropivacaine Injection Application Introduction
  2. 5.1.1 Major Nerve Block
  3. 5.1.2 Surgical Anesthesia
  4. 5.1.3 Acute Pain Management
  5. 5.1.4 Other
  6. 5.2 Global Ropivacaine Injection Sales by Application
  7. 5.2.1 Global Ropivacaine Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ropivacaine Injection Sales by Application (2021-2032)
  9. 5.2.3 Global Ropivacaine Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global Ropivacaine Injection Revenue by Application
  11. 5.3.1 Global Ropivacaine Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ropivacaine Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global Ropivacaine Injection Revenue Market Share by Application (2021-2032)
6 Global Ropivacaine Injection Sales by Region
  1. 6.1 Global Ropivacaine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ropivacaine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Ropivacaine Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Ropivacaine Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ropivacaine Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ropivacaine Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ropivacaine Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ropivacaine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ropivacaine Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ropivacaine Injection Revenue by Region
  1. 7.1 Global Ropivacaine Injection Revenue by Region
  2. 7.1.1 Global Ropivacaine Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ropivacaine Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Ropivacaine Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Ropivacaine Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ropivacaine Injection Revenue (2021-2032)
  8. 7.2.2 North America Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ropivacaine Injection Revenue (2021-2032)
  11. 7.3.2 Europe Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ropivacaine Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ropivacaine Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ropivacaine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical Co.,Ltd
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
  7. 8.2 Yangzi River Pharmaceutical Group
  8. 8.2.1 Yangzi River Pharmaceutical Group Company Information
  9. 8.2.2 Yangzi River Pharmaceutical Group Business Overview
  10. 8.2.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Product Portfolio
  12. 8.2.5 Yangzi River Pharmaceutical Group Recent Developments
  13. 8.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
  14. 8.3.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information
  15. 8.3.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Business Overview
  16. 8.3.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product Portfolio
  18. 8.3.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments
  19. 8.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd
  20. 8.4.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Information
  21. 8.4.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Business Overview
  22. 8.4.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product Portfolio
  24. 8.4.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Ropivacaine Injection Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  32. 8.6.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Information
  33. 8.6.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
  34. 8.6.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product Portfolio
  36. 8.6.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Ropivacaine Injection Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Sintetica SA
  44. 8.8.1 Sintetica SA Company Information
  45. 8.8.2 Sintetica SA Business Overview
  46. 8.8.3 Sintetica SA Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sintetica SA Ropivacaine Injection Product Portfolio
  48. 8.8.5 Sintetica SA Recent Developments
  49. 8.9 SGPharma
  50. 8.9.1 SGPharma Company Information
  51. 8.9.2 SGPharma Business Overview
  52. 8.9.3 SGPharma Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SGPharma Ropivacaine Injection Product Portfolio
  54. 8.9.5 SGPharma Recent Developments
  55. 8.10 Nephron Pharmaceuticals
  56. 8.10.1 Nephron Pharmaceuticals Company Information
  57. 8.10.2 Nephron Pharmaceuticals Business Overview
  58. 8.10.3 Nephron Pharmaceuticals Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nephron Pharmaceuticals Ropivacaine Injection Product Portfolio
  60. 8.10.5 Nephron Pharmaceuticals Recent Developments
  61. 8.11 Manus Aktteva Biopharma LLP
  62. 8.11.1 Manus Aktteva Biopharma LLP Company Information
  63. 8.11.2 Manus Aktteva Biopharma LLP Business Overview
  64. 8.11.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Product Portfolio
  66. 8.11.5 Manus Aktteva Biopharma LLP Recent Developments
  67. 8.12 Anant Pharmaceuticals
  68. 8.12.1 Anant Pharmaceuticals Company Information
  69. 8.12.2 Anant Pharmaceuticals Business Overview
  70. 8.12.3 Anant Pharmaceuticals Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Anant Pharmaceuticals Ropivacaine Injection Product Portfolio
  72. 8.12.5 Anant Pharmaceuticals Recent Developments
  73. 8.13 Akorn
  74. 8.13.1 Akorn Company Information
  75. 8.13.2 Akorn Business Overview
  76. 8.13.3 Akorn Ropivacaine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Akorn Ropivacaine Injection Product Portfolio
  78. 8.13.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ropivacaine Injection Value Chain Analysis
  2. 9.1.1 Ropivacaine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ropivacaine Injection Production Mode & Process
  6. 9.2 Ropivacaine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ropivacaine Injection Distributors
  9. 9.2.3 Ropivacaine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst